Related Articles
Improving immunotherapy for colorectal cancer using dendritic cells combined with anti-programmed death-ligand in vitro
High farnesoid X receptor expression predicts favorable clinical outcomes in PD‑L1<sup>low/negative</sup> non‑small cell lung cancer patients receiving anti‑PD‑1‑based chemo‑immunotherapy
Regulation of PD-L1 expression in a high-grade invasive human oral squamous cell carcinoma microenvironment
Chemotherapy enhances programmed cell death 1/ligand 1 expression via TGF-β induced epithelial mesenchymal transition in non-small cell lung cancer
Significance of PD‑L1 clones and C‑MET expression in hepatocellular carcinoma